Immunome (IMNM) Enterprise Value: 2023-2025
Historic Enterprise Value for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $746.7 million.
- Immunome's Enterprise Value rose 17.06% to $746.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.1 million, marking a year-over-year increase of 36.57%. This contributed to the annual value of $445.6 million for FY2024, which is 39.65% up from last year.
- As of Q3 2025, Immunome's Enterprise Value stood at $746.7 million, which was up 37.99% from $541.1 million recorded in Q2 2025.
- Immunome's 5-year Enterprise Value high stood at $1.2 billion for Q1 2024, and its period low was $11.3 million during Q3 2023.
- Moreover, its 3-year median value for Enterprise Value was $445.6 million (2024), whereas its average is $423.2 million.
- Per our database at Business Quant, Immunome's Enterprise Value skyrocketed by 6,939.36% in 2024 and then tumbled by 76.98% in 2025.
- Quarterly analysis of 3 years shows Immunome's Enterprise Value stood at $319.1 million in 2023, then soared by 39.65% to $445.6 million in 2024, then grew by 17.06% to $746.7 million in 2025.
- Its last three reported values are $746.7 million in Q3 2025, $541.1 million for Q2 2025, and $267.9 million during Q1 2025.